Dark

Check out our API

FLDM
FLUIDIGM CORP (DELAWARE)
stock NASDAQ

Inactive

Apr 5, 2022

3.70USD-7.268%(-0.29)526,846

Pre-market

0.00USD-100.000%(-3.99)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 24, 2022

12:42PM EST Casdin Capital, Viking Global Investors Inject $250M In Fluidigm Benzinga

08:43AM EST Fluidigm Announces $250M Capital Infusion From Casdin Capital And Viking Global Investors And Rebranding To Standard BioTools Inc. Benzinga

08:30AM EST Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions GlobeNewswire Inc

Jan 11, 2022

08:21AM EST Fluidigm Sees Prelim. Q4 Sales $38M-$38.3M vs $32.8M Est., Sees Prelim. FY21 Sales $130.3M-$130.6M vs $125M Est. Benzinga

08:06AM EST Rover Labs Reports Will Use Fluidigm Technology For Saliva-Based COVID-19 Testing In Public Schools In State Of New Jersey, No Terms Disclosed Benzinga

08:00AM EST Fluidigm Announces Preliminary Revenue Exceeding Guidance for the GlobeNewswire Inc

Jan 5, 2022

11:07AM EST Stocks That Hit 52-Week Lows On Wednesday Benzinga

Jan 4, 2022

10:58AM EST Stocks That Breached 52-Week Lows Today Benzinga

Dec 7, 2021

08:43AM EST Fluidigm Confirms Its Advanta Dx SARS-CoV-2 PCR Assay Detects Omicron Variant Benzinga

08:30AM EST Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the GlobeNewswire Inc

Dec 1, 2021

10:07AM EST 'A brand new #PCR setup for the Senckenberg Gesellschaft fr Naturforschung Research Institute in #Frankfurt! The team is ready to increase their throughput...' -Tweet From Fluidigm Benzinga

Nov 16, 2021

08:30AM EST Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual GlobeNewswire Inc

Nov 12, 2021

12:08PM EST Watching Shares Of Fluidigm; Co Tweets 'Join us now for this exciting announcement!' Benzinga

Nov 11, 2021

08:30AM EST Biomark X Offers Industry-Leading Advantages in Speed, Throughput, GlobeNewswire Inc

Nov 9, 2021

11:04AM EST Fluidigm Cuts FY21 Sales Guidance From $134M-$140M To $123M-$127M vs $137M Est. Benzinga

11:02AM EST Fluidigm Says Is 'undertaking a review of various options' Benzinga

11:02AM EST Fluidigm Q3 EPS $(0.07) Beats $(0.22) Estimate, Sales $28.50M Miss $30.00M Estimate Benzinga

Nov 8, 2021

04:02PM EST Board Undertaking Review of Range of Value-Enhancing Opportunities GlobeNewswire Inc

04:00PM EST Franklin Templeton Canada Announces November ETF Cash Distributions and PR Newswire

08:30AM EST Imaging Mass Cytometry Utilized to Seek Molecular Links between GlobeNewswire Inc

05:06AM EST Earnings Scheduled For November 8, 2021 Benzinga

Oct 20, 2021

08:30AM EDT Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced thatit will report third quarter 2021 financial results on Monday, November 8, 2021, after the close of the market. GlobeNewswire Inc

Oct 18, 2021

08:30AM EDT Fluidigm 2021 IMC Summit Focuses on Uncovering GlobeNewswire Inc

Oct 12, 2021

08:36AM EDT Fluidigm Announces Co-Marketing Program Under Visiopharm Collaboration Benzinga

08:30AM EDT Fluidigm Announces New Co-Marketing Program under Collaboration GlobeNewswire Inc

Sep 28, 2021

08:31AM EDT Fluidigm Announces Collaboration Agreement With Karolinska Institutet To Accelerate Customer Adoption Of New CyTOF XT Benzinga

08:30AM EDT Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration agreement with the Karolinska Institutet for research applications and product development utilizing CyTOF XT, the fourth-generation platform based on Fluidigms pioneering CyTOF technology. GlobeNewswire Inc

Sep 2, 2021

08:30AM EDT Fluidigm to Participate in the Cantor Virtual Global Healthcare GlobeNewswire Inc

Aug 31, 2021

11:27AM EDT Return on Capital Employed Insights for Fluidigm Benzinga

08:35AM EDT Fluidigm Highlights Publication Of New Data Further Validating Potential Of Its Mass Cytometry Technologies To Enable Deep Profiling Of Immune, Inflammatory Responses Benzinga

08:30AM EDT Findings in Nature Communications Provide Insights That May Help Guide Patient Care GlobeNewswire Inc

Aug 17, 2021

10:51AM EDT Fluidigm Option Alert: Sep 17 $7.5 Calls at the Ask: 2019 @ $0.35 vs 6478 OI; Ref=$6.685 Benzinga

Aug 13, 2021

01:30PM EDT Fluidigm Option Alert: Jan 21 $7.5 Calls Sweep (37) near the Ask: 530 @ $0.9 vs 588 OI; Ref=$6.67 Benzinga

Aug 9, 2021

11:14AM EDT Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that company management will participate in the following investor event: GlobeNewswire Inc

Aug 6, 2021

06:29AM EDT Fluidigm Q2 Earnings Ahead Of Street Expectations, But Sees Lower Revenues From COVID-19 Products Benzinga

Aug 5, 2021

04:17PM EDT Fluidigm Sees Q3 Sales $29M-$31M vs. $33.92M Est., FY21 Sales $134M-$140M Vs. $135.43M Est. Benzinga

04:15PM EDT Fluidigm Q2 EPS $(0.12) Beats $(0.20) Estimate, Sales $31.00M Beat $30.57M Estimate Benzinga

09:34AM EDT Ultivue Announces Co-Marketing Deal With Fluidigm For Biomarker Imaging Solutions For Precision Medicine RTTNews

09:30AM EDT Ultivue Announces Co-Marketing Agreement with Fluidigm for Biomarker Imaging Solutions for Precision Medicine Business Wire

08:38AM EDT Fluidigm Reports Co-Marketing Deal With Ultivue For Biomarker Imaging Solutions For Precision Medicine, No Terms Disclosed Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 3, 2021

04:56PM EDT 'The Advanta SARS-CoV-2 Mutation Assay Panel can be used to identify the Delta+ variant and infer the Delta variant from prevailing epidemiology...' -Tweet from Fluidigm Benzinga

08:47AM EDT Fluidigm Granted U.S. Patent Titled 'Methods and kits for extracting nucleic acids from paraffin embedded samples' Benzinga

Jul 28, 2021

08:50AM EDT Fluidigm Stock Shoots Higher On Bloomberg Report Of Exploring Potential Sale Benzinga

07:18AM EDT Fluidigm is Exploring a Sale -Late Tuesday Bloomberg Report Benzinga

05:30AM EDT Bloomberg Reported Tuesday, Fluidigm is Exploring a Sale Benzinga

Jul 14, 2021

02:32PM EDT Fluidigm Shares At Session Low, Down ~4.5%; Seeing 931K Share Block Trade At $5.53/Share Benzinga

Jul 8, 2021

04:01PM EDT Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced thatit will report second quarter 2021 financial results on Thursday, August 5, 2021, after the close of the market. GlobeNewswire Inc

Jun 17, 2021

10:20AM EDT Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. RTTNews

07:44AM EDT Rover Labs Utilizes Fluidigm Technology To Offer RT-PCR COVID-19 Testing To 50 New York City Public Schools RTTNews

07:34AM EDT Rover Labs To Provide COVID-19 Testing To 50 NYC Public Schools Using Fluidigm Technology Benzinga

07:31AM EDT Rover Labs Provides Saliva-based COVID-19 Testing to New York City Public PR Newswire

May 25, 2021

02:01PM EDT Fluidigm Shares Tick Higher Following Co. Release Highlighting Launch Of CyTOF XT For 'the design and execution of deep cell profiling studies, standardize sample analysis with reproducible workflows and automation and accelerate novel therapeutic...' Benzinga

02:00PM EDT Next-Generation CyTOF XT Redefines Cytometry with Advances in GlobeNewswire Inc

May 24, 2021

08:30AM EDT Imaging Mass Cytometry Utilized by Global Consortium Focused on GlobeNewswire Inc

May 14, 2021

08:30AM EDT Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the companys management will participate in several upcoming investor conferences and provide updates on the companys business strategy and growth plans. GlobeNewswire Inc

May 10, 2021

01:30PM EDT Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event GlobeNewswire Inc

May 7, 2021

10:01AM EDT Fluidigm shares were trading lower after the company reported worse-than-expected Q1 EPS results and issued Q2 and FY21 sales guidance below estimates. Benzinga

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

05:27PM EDT Fluidigm: Q1 Earnings Insights Benzinga

04:10PM EDT Fluidigm Sees Q2 2021 Revs $30M-32M Vs $35.52M Est Benzinga

04:09PM EDT Fluidigm Sees FY 2021 Revs $134M-$140M Vs $148.85M Est Benzinga

04:07PM EDT Fluidigm Q1 EPS $(0.15) Misses $(0.14) Estimate, Sales $32.79M Beat $31.97M Estimate Benzinga

08:30AM EDT Data Published in Nature Communications Demonstrate the Power of GlobeNewswire Inc

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 8, 2021

08:30AM EDT Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced thatit will report first quarter 2021 financial results on Thursday, May 6, 2021, after the close of the market. GlobeNewswire Inc

Mar 1, 2021

12:51PM EST Fluidigm Gets EUA Nod For Home Sample Collection Kit For Advanta COVID-19 Assay Benzinga

08:32AM EST FDA GrantsEmergency Use Authorization For AZOVA COVID-19 Test Collection Kit Home Collection Kit For Usw With Fluidigm Advanta Dx SARS-CoV-2 RT-PCR Assay Benzinga

08:30AM EST Collaboration Agreement to Market AZOVA COVID-19 Test Collection Kit Online GlobeNewswire Inc

Feb 10, 2021

04:28PM EST Recap: Fluidigm Q4 Earnings Benzinga

04:17PM EST Fluidigm Sees Q1 Sales $30M-$33M vs. $47.62M Est., FY21 Sales $144M-$155M Vs. $198.25M Est. Benzinga

04:17PM EST CORRECTION: Fluidigm Sees Q1 Sales $30M-$33M vs. $47.62M Est., FY21 Sales $144M-$155M Vs. $198.25M Est. Benzinga

04:14PM EST Fluidigm Q4 EPS $(0.13) Misses $(0.07) Estimate, Sales $44.60M Miss $50.72M Estimate Benzinga

04:05PM EST Fluidigm Reports George Mason University Is Providing Saliva-Based COVID-19 Testing Using Advanta Dx SARS-CoV-2 RT-PCR Assay On Co.'s Biomark HD System Benzinga

04:05PM EST Fluidigm Announces Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire Inc

04:04PM EST Fluidigm Reports Collab With Zhejiang PuLuoTing Health Technology Co. To Market Co.'s CyTOF Technology To Clinical Labs In China, No Terms Disclosed Benzinga

04:03PM EST Fluidigm Sees Q1 EPS $0.22-$0.42, Sales $118M-$138M Benzinga

04:02PM EST Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced thatGeorge Mason University in Fairfax, Va., is providing saliva-based COVID-19 testing using the Advanta Dx SARS-CoV-2 RT-PCR Assay on the Fluidigm Biomark HD system. GlobeNewswire Inc

04:02PM EST Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a supply and distribution agreement with Zhejiang PuLuoTing Health Technology Co. Ltd (PLT Tech) to market Fluidigm CyTOF technology, panels and reagents to clinical labs in China. GlobeNewswire Inc

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

03:43AM EST Earnings Scheduled For February 10, 2021 Benzinga

Feb 9, 2021

10:11AM EST Earnings Preview: Fluidigm Benzinga

08:32AM EST Fluidigm Reports Its Mass Cytometry Technology, Maxpar Direct Immune Profiling Assay To Be Used In Logitudinal Study Of ~250 Pediatric Patients Infected With SARS-CoV-2 Benzinga

08:30AM EST Researchers Seek Insight into Development and Progression of Multisystem Inflammatory Syndrome in Children GlobeNewswire Inc

Feb 6, 2021

12:42PM EST The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight Benzinga

Feb 4, 2021

04:02PM EST Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the companys management will participate in investor meetings at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021. GlobeNewswire Inc

Jan 26, 2021

08:33AM EST Fluidigm Highlights Helix Specialty Diagnostics PArtnering Wih Genomic LTC DX To 'provide COVID-19 testing using the Advanta Dx SARS-CoV-2 RT-PCR Assay on the Fluidigm Biomark HD system.' Benzinga

08:30AM EST Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced thatHelix Specialty Diagnostics is partnering with Genomic LTC DX to provide COVID-19 testing using the Advanta Dx SARS-CoV-2 RT-PCR Assay on the Fluidigm Biomark HD system. GlobeNewswire Inc

Jan 22, 2021

10:58AM EST Looking Into Fluidigm's Return On Capital Employed Benzinga

10:17AM EST Shares of Fluidigm Corporation (FLDM) are climbing more than 14% Friday morning after the company recieved CE-IVD mark for its saliva based Advanta Dx SARS-CoV-2 RT-PCR assay for Covid-19. RTTNews

07:22AM EST The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa Benzinga

Jan 21, 2021

04:06PM EST Fluidigm Reports Receives CE-IVD Mark For Its Advanta Dx SARS-CoV-2 RT-PCR Assay Test Benzinga

04:05PM EST Fluidigm Receives CE-IVD Mark for Its Saliva-Based Advanta Dx GlobeNewswire Inc

Jan 7, 2021

04:02PM EST Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced thatit will report fourth quarter and full year 2020 financial results on Wednesday, February 10, 2021, after the close of the market. GlobeNewswire Inc

Jan 5, 2021

08:33AM EST Fluidigm Highlights Publication Of Data In Gastroenterology Demonstrating Co.'s Imaging Mass Cytometry Benzinga

08:30AM EST Study Highlighting IMC Application in Both Protein and RNA Detection Conducted by Researchers at Fluidigm Center of Excellence forImaging Mass Cytometry at Georgetown Lombardi Comprehensive Cancer Center GlobeNewswire Inc

Dec 15, 2020

04:05PM EST Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of GlobeNewswire Inc

Nov 25, 2020

12:12PM EST Fluidigm Tweets 'Interesting new research study uses Fluidigm #microfluidics to improve turnaround time for test result delivery and increase #SARSCoV2 testing capacity. With a new surge in cases, increased testing capacity is paramount.' Benzinga

Nov 24, 2020

08:34AM EST Fluidigm Annonces India's Central Drugs Standard Control Organisation Has Granted Commercial License For Co.'s Advanta Dx SARS-CoV-2 RT-PCR Assay Benzinga

08:30AM EST Key Regulatory Body in India Grants Commercial License for GlobeNewswire Inc

Nov 22, 2020

11:37AM EST Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (Fluidigm or the Company) (NASDAQ:FLDM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. GlobeNewswire Inc

Nov 20, 2020

09:55PM EST Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the companys management will participate in the Piper Sandler 32ndAnnual Virtual Healthcare Conference on Tuesday, December 1, and Wednesday, December 2. GlobeNewswire Inc

08:52AM EST FLDM FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, GlobeNewswire Inc

Nov 19, 2020

11:00AM EST FLDM Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fluidigm Corporation Investors of Class Action and Lead Plaintiff Deadline: November 20, 2020 Business Wire

10:54AM EST Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) from February 7, 2019 through November 5, 2019, inclusive (the Class Period). The lawsuit seeks to recover damages for Fluidigm Corporation investors under the federal securities laws. GlobeNewswire Inc

08:30AM EST Weill Cornell Medicine Researchers Utilize Fluidigm Hyperion Imaging System to Identify a Phenotype of Immune Cell Activity Distinct from Other Lung Infections GlobeNewswire Inc

08:00AM EST Investors with losses are encouraged to contact the firm before November 20, 2020; click here to submit trade information GlobeNewswire Inc

Nov 18, 2020

04:04PM EST FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors GlobeNewswire Inc

11:01AM EST Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class PR Newswire

10:00AM EST FLDM & WRTC Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds GlobeNewswire Inc

Nov 17, 2020

09:00PM EST DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That GlobeNewswire Inc

08:36AM EST Fluidigm Announces 'COVID-19 Community Connect' Program To 'Increase Access of Saliva-Based SARS-CoV-2 Testing for Communities' Benzinga

08:30AM EST Fluidigm COVID-19 Community Connect Program Builds a Network of GlobeNewswire Inc

Nov 16, 2020

11:15AM EST The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Nov 13, 2020

06:53PM EST Investors of Important November 20 Deadline in Securities Class Action - FLDM PR Newswire

09:52AM EST Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive. If you wish to serve as lead plaintiff, you must move the Court before the NOVEMBER 20, 2020 DEADLINE. GlobeNewswire Inc

08:00AM EST Investors with losses are encouraged to contact the firm before November 20, 2020; click here to submit trade information GlobeNewswire Inc

Nov 12, 2020

03:53PM EST Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) from February 7, 2019 through November 5, 2019, inclusive (the Class Period). The lawsuit seeks to recover damages for Fluidigm Corporation investors under the federal securities laws. GlobeNewswire Inc

11:31AM EST Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Nov 11, 2020

04:57PM EST Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (Fluidigm or the Company) (NASDAQ: FLDM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. GlobeNewswire Inc

03:53PM EST ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fluidigm Corporation GlobeNewswire Inc

Nov 10, 2020

11:30AM EST Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fluidigm Corporation (Fluidigm or Company) (NASDAQ:FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the Class Period). GlobeNewswire Inc

10:26AM EST Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation PR Newswire

08:30AM EST Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the companys management will participate in investor meetings and present updates regarding Fluidigms business strategy and financial performance at the Stifel Virtual Healthcare Conference. GlobeNewswire Inc

Nov 9, 2020

11:00AM EST The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Nov 8, 2020

02:15AM EST Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (Fluidigm or the Company) (NASDAQ:FLDM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. GlobeNewswire Inc

Nov 6, 2020

05:06PM EST INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class GlobeNewswire Inc

Nov 5, 2020

05:08PM EST Fluidigm Q3 EPS $0.03 Beats $(0.20) Estimate, Sales $39.86M Beat $32.46M Estimate Benzinga

04:28PM EST Recap: Fluidigm Q3 Earnings Benzinga

08:35AM EST Fluidigm And Healthvana Partner To Offer COVID-19 Test Results Delivery Through Innovative Digital Platform Benzinga

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 4, 2020

03:09PM EST Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) from February 7, 2019 through November 5, 2019, inclusive (the Class Period). The lawsuit seeks to recover damages for Fluidigm Corporation investors under the federal securities laws. GlobeNewswire Inc

Nov 3, 2020

11:30AM EST Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

11:00AM EST The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

08:34AM EST Fluidigm Highlights Co's Mass Cytometry Technologies Utilized In More Than 100 National Clinical Trials Benzinga

08:30AM EST Fluidigm Mass Cytometry Technologies, Including CyTOF, Imaging GlobeNewswire Inc

Nov 2, 2020

12:00PM EST Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fluidigm Corporation (Fluidigm or Company) (NASDAQ:FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the Class Period). GlobeNewswire Inc

08:32AM EST Fluidigm Announces Dante Labs Will Offer COVID-19 Testing Services In Europe Utilizing A Fluidigm Pathogen Detection Kit Benzinga

08:30AM EST Global Pioneer in Direct-to-Consumer Genomic Testing Chooses Fluidigm Saliva-Based Solution GlobeNewswire Inc

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 31, 2020

11:31PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of PR Newswire

Oct 30, 2020

04:52PM EDT ROSEN, A LEADING LAW FIRM, Reminds Fluidigm Corporation Investors GlobeNewswire Inc

03:56PM EDT INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class GlobeNewswire Inc

Oct 27, 2020

12:00PM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

11:00AM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

09:47AM EDT Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation PR Newswire

Oct 26, 2020

05:27PM EDT Important November 20 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - FLDM PR Newswire

Oct 24, 2020

05:45PM EDT Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the Class Period) of the important November 20, 2020 lead plaintiff deadline. The lawsuit seeks to recover damages for Fluidigm investors under the federal securities laws. GlobeNewswire Inc

Oct 22, 2020

01:19PM EDT FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors GlobeNewswire Inc

Oct 21, 2020

01:00PM EDT NXTC, FLDM & WRTC Class Action Reminders: Bronstein, Gewirtz & GlobeNewswire Inc

11:45AM EDT The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class PR Newswire

Oct 19, 2020

01:00PM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

10:33AM EDT Shares of Fluidigm Corp. (FLDM) are rising more than 6 percent or $0.45 in Monday's morning trade at $7.20. RTTNews

10:30AM EDT Looking Into Fluidigm's Return On Capital Employed Benzinga

05:59AM EDT Fluidigm Shares +18.5% Premarket; Trump Administration Announced Friday it was Providing Co's Saliva Test at Surge Testing Site in Waco, TX Benzinga

Oct 17, 2020

06:45PM EDT Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the Class Period) of the important November 20, 2020 lead plaintiff deadline. The lawsuit seeks to recover damages for Fluidigm investors under the federal securities laws. GlobeNewswire Inc

Oct 15, 2020

02:19PM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Oct 14, 2020

12:21PM EDT FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors GlobeNewswire Inc

11:30AM EDT Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fluidigm Corporation (Fluidigm or Company) (NASDAQ:FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the Class Period). GlobeNewswire Inc

Oct 13, 2020

09:14AM EDT Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation PR Newswire

Oct 12, 2020

09:31PM EDT Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (Fluidigm or the Company) (NASDAQ:FLDM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. GlobeNewswire Inc

11:45AM EDT Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the Class Period) of the important November 20, 2020 lead plaintiff deadline. The lawsuit seeks to recover damages for Fluidigm investors under the federal securities laws. GlobeNewswire Inc

Oct 9, 2020

05:15PM EDT Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - FLDM PR Newswire

01:00PM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Oct 8, 2020

05:19PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of PR Newswire

11:30AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

10:00AM EDT Fluidigm shares are trading higher after the company announced it will provide Advanta COVID-19 tests for as low as $5 per test at colleges and universities. Benzinga

09:40AM EDT Fluidigm Option Alert: Oct 16 $7.5 Calls Sweep (5) near the Ask: 675 @ $1.4 vs 4883 OI; Earnings 11/5 After Close Ref=$8.755 Benzinga

08:33AM EDT Fluidigm To Provide Advanta COVID-19 Tests For As Low As $5/Test At Colleges and Universities Benzinga

08:30AM EDT Fluidigm COVID-19 Campus Safeguard Program Improves Availability of Noninvasive, Saliva-Based SARS-CoV-2 Testsfor Higher EducationInstitutions GlobeNewswire Inc

Oct 7, 2020

12:31PM EDT DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming PR Newswire

12:10PM EDT FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors GlobeNewswire Inc

Oct 6, 2020

04:02PM EDT Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced thatit will report third quarter 2020 financial results on Thursday, November 5, 2020, after the close of the market. GlobeNewswire Inc

12:35PM EDT Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the Class Period). The lawsuit seeks to recover investor losses under the federal securities laws. GlobeNewswire Inc

Oct 5, 2020

08:39PM EDT Investor Alert: Kaplan Fox Investigates Fluidigm For Potential Securities Fraud PR Newswire

Oct 3, 2020

01:30PM EDT LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact PR Newswire

Oct 2, 2020

01:00PM EDT Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class PR Newswire

11:45AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

11:00AM EDT FLDM Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fluidigm Corporation Investors of Class Action and Encourages Shareholders to Contact the Firm Business Wire

Sep 30, 2020

04:00PM EDT LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who purchased Fluidigm Corporation PR Newswire

10:07AM EDT FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors GlobeNewswire Inc

Sep 29, 2020

03:01PM EDT Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation PR Newswire

06:24AM EDT Fluidigm Executed Contract With NIH As An Amendment To Letter Contract To Expand Production Capacity And Throughput Capabilities For Covid-19 Testing; Funding For Project Was Increased To About $34M Upon Achievement Of Milestones Benzinga

Sep 28, 2020

07:30PM EDT Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the Class Period). The lawsuit seeks to recover damages for Fluidigm investors under the federal securities laws. GlobeNewswire Inc

10:22AM EDT FLDM INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation Business Wire

Sep 25, 2020

07:10PM EDT Lawsuit Against Fluidigm Corporation; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FLDM PR Newswire

10:01AM EDT FLDM SHAREHOLDER ALERT: Bernstein Liebhard Announces that a Securities Fraud Class Action has Been Filed Against Fluidigm Corporation Business Wire

10:00AM EDT FLDM Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC GlobeNewswire Inc

Sep 24, 2020

10:29PM EDT The Portnoy Law Firm advises Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. GlobeNewswire Inc

09:47AM EDT FLDM INVESTOR ALERT: Bernstein Liebhard is Investigating Fluidigm Corporation For Violations of the Securities Laws Business Wire

Sep 23, 2020

11:33AM EDT Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who purchased Fluidigm Corporation (Fluidigm or the Company) (NASDAQ: FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the Class Period). GlobeNewswire Inc

10:00AM EDT Corporation Investors of Class Action and Encourages Shareholders to Contact the Firm PR Newswire

09:02AM EDT FLDM LOSSES ALERT: Bernstein Liebhard is Investigating Fluidigm Corporation For Violations of the Securities Laws Business Wire

Sep 21, 2020

08:56PM EDT FLDM CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Fluidigm Corporation Business Wire

Sep 18, 2020

02:07PM EDT Fluidigm Option Alert: Oct 16 $15 Calls Sweep (11) near the Ask: 888 @ $0.25 vs 691 OI; Earnings 11/3 After Close [est] Ref=$8.04 Benzinga

02:05PM EDT Fluidigm Option Alert: Oct 16 $5 Calls Sweep (31) near the Ask: 643 @ $3.2 vs 180 OI; Earnings 11/3 After Close [est] Ref=$7.88 Benzinga

Sep 16, 2020

08:45AM EDT CANCERPREV Cross-Disciplinary Program Expands Knowledge of Cancer Development to Deliver New Insights into Prevention Strategies GlobeNewswire Inc

08:31AM EDT ImmunoGenomics, Vero Diagnostics Providing Coronavirus Testing With Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay On Biomark HD Platform Benzinga

08:30AM EDT ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing GlobeNewswire Inc

Sep 15, 2020

08:30AM EDT Virtual Event Showcases CyTOF Technology and Its Use in High-Parameter Suspension Mass Cytometry and Imaging Mass Cytometry GlobeNewswire Inc

Sep 8, 2020

08:39AM EDT Fluidigm Announces Progress On Rapid Acceleration Of Diagnostics Project RTTNews

08:36AM EDT Fluidigm Achieves Initial Milestone Under NIH Rapid Acceleration Of Diagnostics Agreement; Expects To Receive All $12M In Funding Associated With Letter Contract By End Of Q3 Benzinga

08:30AM EDT Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced progress on the Companys Rapid Acceleration of Diagnostics (RADx) project. GlobeNewswire Inc

06:19AM EDT Fluidigm Corporation Reports Sale of 2.48M Shares Between August 13, 2020 through September 3, 2020 under Previously Announced ATM Equity Offering Program Benzinga

Sep 2, 2020

04:02PM EDT Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the companys management will participate in investor meetings and present updates regarding Fluidigms business strategy and financial performance at the Cantor Virtual Global Healthcare Conference. GlobeNewswire Inc

Sep 1, 2020

10:59AM EDT Fluidigm Shares At Session Low Amid Block Trade Of 587K Shares At $7.30 At The Bid Benzinga

Aug 27, 2020

10:58AM EDT UBS Maintains Buy on Fluidigm, Raises Price Target to $16 Benzinga

Aug 26, 2020

02:31PM EDT Mid-Afternoon Market Update: Dow Rises 90 Points; Salesforce.com Shares Surge On Upbeat Q2 Results Benzinga

12:22PM EDT Mid-Day Market Update: Nasdaq Jumps 150 Points; Anaplan Shares Gain Following Q2 Results Benzinga

11:17AM EDT Why Fluidigm's Stock Is Trading Higher Today Benzinga

10:22AM EDT Mid-Morning Market Update: Markets Mostly Higher; Dicks Sporting Tops Q2 Estimates Benzinga

10:04AM EDT Shares of Fluidigm Corp. (FLDM) surged over 35% on Wednesday morning after the company said the U.S. Food and Drug Administration granted emergency use authorization for its saliva-based COVID-19 test. RTTNews

09:25AM EDT Fluidigm Shares Volatile; Citron Research Tweets '$FLDM to $35 and higher. FDA Emergency Use Authorization first step. Company will change COVID-19 testing forever as their saliva-based test Demonstrated 100 Percent Agreement with Nasopharyngeal Assays' Benzinga

08:32AM EDT Looking Into Fluidigm's Return On Capital Employed Benzinga

05:49AM EDT Fluidigm Granted FDA EUA for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19 Benzinga

Aug 25, 2020

11:00PM EDT Easy-to-Administer Saliva Test for COVID-19 Available for Immediate Shipment GlobeNewswire Inc

10:14AM EDT Shares of biological research equipment maker Fluidigm Corporation (FLDM) are climbing more than 6% Tuesday morning and touched a new high of $9.35. RTTNews

Aug 21, 2020

11:03AM EDT Fluidigm Shares Move Higher; Co Tweets 'A 33-marker #masscytometry panel and epigenetic landscape profiling (EpiTOF), enabled with #CyTOF technology ... find that gut colonization by S. Typhi causes cell-type-specific #epigenetic changes.' Benzinga

Aug 20, 2020

03:27PM EDT Government Site Shows Fluidigm Contract For US Geological Survey Benzinga

03:03PM EDT Fluidigm Wins Purchase Order From Agricultural Research Service Benzinga

01:58PM EDT Fluidigm Option Alert: Sep 18 $5 Calls Sweep (24) near the Ask: 500 @ $3.397 vs 143 OI; Ref=$8.1199 Benzinga

Aug 10, 2020

12:15PM EDT UBS Maintains Buy on Fluidigm, Raises Price Target to $12 Benzinga

Aug 6, 2020

05:06PM EDT Fluidigm Q2 EPS $(0.07) Beats $(0.23) Estimate, Sales $26.07M Beat $19.07M Estimate Benzinga

Aug 4, 2020

08:31AM EDT Fluidigm Reports Distribution Deal With De Novo Software To Provide Customers Access To Data Analysis Solution For High-Parameter Data Files, No Terms Disclosed Benzinga

08:30AM EDT Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a distribution agreement with De Novo Software to provide customers with access to a data analysis solution for the high-parameter data files generated by mass cytometry using De Novos FCS Express 7 Flow software. GlobeNewswire Inc

Jul 31, 2020

11:11AM EDT Fluidigm Selected For $37M Project Under National Institutes Of Health RADx Initiative Benzinga

11:10AM EDT Fluidigm Selected for $37 Million Project under National GlobeNewswire Inc

Jul 23, 2020

09:52AM EDT Fluidigm Shares Quiet; Co. Tweets: 'Researchers from @UniLeidenNews Medical Center developed and optimized immunodetection conditions for a 34-antibody panel for use on human snap-frozen tissue sections with #imagingmasscytometry...' Benzinga

Jul 20, 2020

03:10PM EDT Fluidigm shares are trading higher after the company announced it filed for an emergency use authorization with the FDA for its rapid turnaround real-time RT-PCR coronavirus test. Benzinga

08:37AM EDT GnomeDX Files For FDA EUA For Rapid Turnaround Real-Time RT-PCR COVID-19 Test Utilizing Fluidigm Biomark HD Platform RTTNews

08:31AM EDT GnomeDX Files For FDA Emergency Use Authorization For Rapid Turnaround Real-Time RT-PCR COVID-19 Test Utilizing Fluidigm Biomark HD Platform Benzinga

08:30AM EDT Test Intended to Expand Availability of COVID-19 Screening Resources in Central Ohio GlobeNewswire Inc

Share